Article
Characterisation of the clinical pharmacokinetics of actinomycin D and the influence of ABCB1 pharmacogenetic variation on actinomycin D disposition in children with cancer.
Clinical pharmacokinetics - 1 Aug 2014
Hill Christopher R, Cole Michael, Errington Julie, Malik Ghada, Boddy Alan V, Veal Gareth J
Abstract excerpt
BACKGROUND AND OBJECTIVE: Despite its important role in cancer treatment, there is currently very limited available information concerning the clinical pharmacology of actinomycin D (Act D). The study was designed to characterise Act D pharmacokinetics and investigate the impact of pharmacogenetic variation on Act D disposition in children with cancer. METHODS: A total of 650 plasma samples collected over an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
